Your browser doesn't support javascript.
loading
The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
Andreou, D; Bielack, S S; Carrle, D; Kevric, M; Kotz, R; Winkelmann, W; Jundt, G; Werner, M; Fehlberg, S; Kager, L; Kühne, T; Lang, S; Dominkus, M; Exner, G U; Hardes, J; Hillmann, A; Ewerbeck, V; Heise, U; Reichardt, P; Tunn, P-U.
Afiliação
  • Andreou D; Department of Orthopedic Oncology, Sarcoma Center Berlin-Brandenburg, Helios Klinikum Berlin-Buch, Academic Teaching Hospital of the Charité Universitätsmedizin, Berlin. Electronic address: dimosthenis.andreou@helios-kliniken.de.
  • Bielack SS; Pediatrics 5-Oncology, Hematology and Immunology, COSS Study Center, Olgahospital, Klinikum Stuttgart, Stuttgart, Germany.
  • Carrle D; Pediatrics 5-Oncology, Hematology and Immunology, COSS Study Center, Olgahospital, Klinikum Stuttgart, Stuttgart, Germany.
  • Kevric M; Pediatrics 5-Oncology, Hematology and Immunology, COSS Study Center, Olgahospital, Klinikum Stuttgart, Stuttgart, Germany.
  • Kotz R; Department of Orthopedic Surgery, University Hospital of Vienna, Vienna, Austria.
  • Winkelmann W; Department of General Orthopedics and Tumororthopedics, University Hospital of Muenster, Muenster, Germany.
  • Jundt G; Department of Pathology, Universitätsspital Basel, Basel, Switzerland.
  • Werner M; Department of Pathology, Sarcoma Center Berlin-Brandenburg, Helios Klinikum Emil von Behring, Berlin, Germany.
  • Fehlberg S; Department of Orthopedic Oncology, Sarcoma Center Berlin-Brandenburg, Helios Klinikum Berlin-Buch, Academic Teaching Hospital of the Charité Universitätsmedizin, Berlin.
  • Kager L; Department of Hematology/Oncology, St Anna Children's Hospital, Vienna, Austria.
  • Kühne T; Division of Oncology/Hematology, University Children's Hospital, Basel, Switzerland.
  • Lang S; Department of Pathology, University Hospital of Vienna, Vienna, Austria.
  • Dominkus M; Department of Orthopedic Surgery, University Hospital of Vienna, Vienna, Austria.
  • Exner GU; Department of Orthopedics, Balgrist University Hospital, Zurich, Switzerland.
  • Hardes J; Department of General Orthopedics and Tumororthopedics, University Hospital of Muenster, Muenster, Germany.
  • Hillmann A; Department of Orthopedics, Klinikum Ingolstadt, Ingolstadt.
  • Ewerbeck V; Department of Orthopedics and Traumatology, University Hospital of Heidelberg, Heidelberg.
  • Heise U; Department of Orthopedics, Albertinen Hospital, Hamburg.
  • Reichardt P; Department of Hematology, Oncology and Palliative Care, Sarcoma Center Berlin-Brandenburg, Helios Klinikum Bad Saarow, Academic Teaching Hospital of the Charité Universitätsmedizin, Bad Saarow, Germany.
  • Tunn PU; Department of Orthopedic Oncology, Sarcoma Center Berlin-Brandenburg, Helios Klinikum Berlin-Buch, Academic Teaching Hospital of the Charité Universitätsmedizin, Berlin.
Ann Oncol ; 22(5): 1228-1235, 2011 May.
Article em En | MEDLINE | ID: mdl-21030381
BACKGROUND: Local recurrence (LR) in osteosarcoma is associated with very poor prognosis. We sought to evaluate which factors correlate with LR in patients who achieved complete surgical remission with adequate margins. PATIENTS AND METHODS: We analyzed 1355 patients with previously untreated high-grade central osteosarcoma of the extremities, the shoulder and the pelvis registered in neoadjuvant Cooperative Osteosarcoma Study Group trials between 1986 and 2005. Seventy-six patients developed LR. RESULTS: Median follow-up was 5.56 years. No participation in a study, pelvic tumor site, limb-sparing surgery, soft tissue infiltration beyond the periosteum, poor response to neoadjuvant chemotherapy, failure to complete the planned chemotherapy protocol and biopsy at a center other than the one performing the tumor resection were significantly associated with a higher LR rate. No differences were found for varying surgical margin widths. Surgical treatment at centers with small patient volume and additional surgery in the primary tumor area, other than biopsy and tumor resection, were significantly associated with a higher rate of ablative surgery. CONCLUSIONS: Patient enrollment in clinical trials and performing the biopsy at experienced institutions capable of undertaking the tumor resection without compromising the oncological and functional outcome should be pursued in the future.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteossarcoma / Recidiva Local de Neoplasia Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2011 Tipo de documento: Article País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteossarcoma / Recidiva Local de Neoplasia Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2011 Tipo de documento: Article País de publicação: Reino Unido